Lead, Asia-Pacific Regulatory Partnerships · NUS Enterprise
MedTech Commercialization Working Group
Every promising medtech innovation deserves a clear, predictable regulatory path to the patients who need it across Asia-Pacific.
I lead regulatory partnerships across Asia-Pacific at NUS Enterprise, helping medtech innovations move from the lab through the region's regulatory pathways toward real commercialization.
My focus is global regulatory harmonization, particularly the evolution of China's medical device registration and quality compliance framework — and the ongoing efforts of organizations like AdvaMed to advance harmonization across borders.
Mapping registration strategy for the China market as classification and review requirements evolve.
Consistent QMS implementation across markets, without duplicating the cost of building and auditing.
Risk management across the product lifecycle, and how post-market data feeds back into compliance.
Ongoing dialogue with regulators and associations, including AdvaMed, toward regulatory convergence.